HOW STEM CELLS WORK

Properties of Stem Cells

Self Renewal
 Types of Stem Cells
Umbilical Cord Blood
Red Blood Cells (RBC) | White Blood Cells (WBC)
| Platelets
Haematopoietic
Stem Cells
Umbilical Cord Lining
Fat (Adipogenic) | Bone (Osteogenic) | Muscles /
Mesenchymal Cardiac Muscles
Stem Cells Cartilage (Chondrogenic) | Brain & Neurons
(Dopaminergic & Neuro)

Gastro-intestinal Tract | Eye (Corneal) | Liver

(Hepatogenic)
Epithelia Skin (Keratogenic) | Pancreatic (Pancreatogenic)
l
When we are talking about
long relationship,
stability matters
 Financial Highlights

Cordlife
Group
Market Capitalisation as
of June’15

S$227
Million
 India Hong Kong/
Macao

[Cordlife Thailand
Philippines

Group] Malaysia

Cordlife Group Limited & it’s subsidiaries Singapore Indonesia

Cordlife Group Limited’s

Investment
 Giving Hope & Saving lives
with Cord Blood Stem Cells

Genetic
Diseases
11%

Blood
Disorder
Cellular 42%
Therapy Cordlife’s Proven
47%
Transplant Track
Report

2002 2009 2010 2011 2012 2013 2014 2015

 Stem Cell Preservation
Process
Step
Registration: Enrolment process & Kit box
1
handover
Step
Collection: Umbilical Cord & Cord Blood is
2
collected
Step Transportation: The collected sample is sent to the
3 lab under required condition

Step Processing: Cord & Cord Blood is further processed

4 to extract stem Cells

Step Cryopreservation: The Stem Cells are stored

5 in vapour
phase of liquid Nitrogen
 Notarise
d
Agreemen
t

*Refer agreement for full details

Umbilical
Cord Blood
is
collected
in 250 ml
Pouch
Scientifically designed
Kit Box along with Two
Foam Bricks
 Cord Blood Processing with
Sepax®2
HSCs can not be expanded as of
now!
Therefore, Every Drop is Precious…

Advantage
US & European FDA Approved
Advanced Optical sensors
(Recovery up to 99.46%)
Time taken to process 35-45
minutes
UCB Protocol used (No HES
used)
Automated reports
Benefit
2013 technology vs. 1978
Manual
25% better recovery
Achieves more viability than
manual
Safe during transplant
No chance of human error
 Umbilical Cord Lining
Processing
 Cell Isolation
 Cell Type Viability Patented
 Cell Type in 18
Patented Confirmation
technology countrie
 Cell Expansion
s

Isolation Report Differentiation Report

Viability & Expandability Report
Only Cordlife provides treatment
option
with 3 Cell Lines
 Haematopoietic Stem Cells (HSC

 Mesenchymal Stem Cells (MSCs)

 Epithelial Stem Cells (EpSCs)

Cryopreservation of
Umbilical Cord Blood & Cord Lining

Umbilical Cord Blood Umbilical Cord

Lining
Qualit
y
Contro
l
Transplan
t Bag
Cryovials
Eva Cryopouch

Cassett
e
 Certificates

DCGI License AABB Certificate WHO GMP Certificate DNV-GL Certificate

2014 2015-17 2014 2015
 Cordlife
Services for
immediate family
members
World Wide
Transportation
in the shortest possible time

Cord Blood within 10

days
Cord tissue within 21 days

NO EXTRA COST
H.L.A Testing

C.F.U Testing

Expansion of stem
cells

Supplementary
Sample
 Cordlife Care Programme

Full Refund
If Sample is used
for transplant
within 18 months

*Refer agreement for full details

 Cordlife Relief Programme

If, Unforeseen circumstances

arise
If, Stem cells are destroyed
Provide suitable Stem Cells within 14
working days,
Or,
Compensation of ₹20,00,000

*Refer agreement for full details

Quality Warranty Programme
If, Stem Cells lose their
Viability,

Internatio
Who nal
Decides Viability
? Standards
Replacemen Compensation
t
₹
20,00,000
within 30 days
 Cordlife Transplant
Programme

Insurance Coverage for

your Immediate Family
members for Umbilical
Cord Blood Stem Cell
Transplant, equivalent
to
S$50,000
*Refer agreement for full details
WE DELIVER WHAT WE PROMISE!
Experience

 Stem cell
banking
Accreditations  Therapy
clients
Financial
Stability
 AABB
 FDA  2 stock
Trust exchanges
Technology  DCGI
 WHO GMP
 Cordlife
 Sepax-2 Promises
 CellOptima  Notarised
Agreement
 ‘Most Transparent
Company’
Awarded by SIAS Investors Choice

We believe in maintaining transparency in our

dealings with our clients. Our transparency
constantly stands out throughout our services. Our
honesty and integrity have been noted and
appreciated world wide, a claim validated by the
title of being the
‘Most Transparent Company’ awarded by the
globally recognised SIAS Investors Choice Awards
(Securities Investors Association, Singapore).
 BASIC PLAN
CORD BLOOD PROCESS UPGRADING FOR SEPEX-2 – 5000- Rs.

Plans 21 years Standard 21 years Flexi -12 21 years Flexi -24 21 years Flexi- 36 21 years Flexi -48

Enrollment Fees 5000 5000 5000 10000 12000

Document
Processing
Charges 300 300 300 300 300

BASIC 50000 4250 2150 1300 990

 PLAN
ONE TIME FLEXI-12 FLEXI-24 FLEXI-36 FLEXI-48

ENROLLMENT FEE 5000 5000 5000 10000 12000

Document
300 300 300 300 300
Processing Charges

CORDSURE 60,000 5,200 2,700 1700 1300

EXPLANT 94,000 8,000 4,100 2,600 2000
EPICORD50M 1,84,000 16,000 NO NO NO

EPICORD500M 3,89,000 33,000 NO NO NO